Pre-screening device for sleep apnea

Sensirion is the leading sensor supplier for OSA (obstructive sleep apnea ) therapy devices such as CPAPs and has an outstanding record in the field of sleep quality management. In 2016, Frost & Sullivan revealed that only one out of five Americans with obstructive sleep apnea are properly diagnosed. A shocking 23.5 out of 29.4 million Americans with OSA are undiagnosed and remain untreated which amounts to tremendous economic costs. The authors estimate that over $10 billion could be saved every year if all Americans who suffer from OSA were properly diagnosed and treated. Sensirion's tiny sensors enable inexpensive and convenient pre-screening at home due to their unmatched sensitivity. One idea how such a pre-screening device could look like can be found on our developers Website.